Sotera Health Company (SHC) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 1:30 PM EDT
Company Participants
Alton Shader – CEO & Director
Conference Call Participants
Rahul Sood
Presentation
Rahul Sood
Okay. Good afternoon, everyone. I’m Rahul Sood, Managing Director in the Healthcare Investment Banking Group at Wells Fargo. On the stage, I’m joined by CEO of Sotera Health, Alton Shader. Alton, welcome.
Alton Shader
CEO & Director
Thank you. It’s good to be here.
Rahul Sood
Thank you for being here with us.
Question-and-Answer Session
Rahul Sood
So for the investors who may be newer to the story, can you provide a brief overview of Sotera Health and explain why the services provided by your three different segments, Sterigenics, Nordion and Nelson Labs are so critical for your customers?
Alton Shader
CEO & Director
Yes, absolutely. So Sotera Health’s mission is safeguarding global health. And what we do is we advance that mission through three business units in Sterigenics, Nelson Labs and Nordion. And our largest business unit is Sterigenics, and Sterigenics is a leading global provider of outsourced sterilization services to both the medical device and pharmaceutical markets. We offer all major sterilization modalities and technologies and we’ve got 49 facilities around the world. Now sterilization for those of you who aren’t familiar, is the last government-mandated step that a med device, for example, needs to go through before it is available to be used by providers or for patients. The way the process works is for a medical device, a med tech OEM will manufacture the product, they’ll package the product, they’ll box the product, they’ll put it on a pallet and they’ll deliver it to one of our 49 facilities. We will then sterilize that product, utilizing one of the technologies or modalities that it’s been validated for. And once that sterilization process is complete, it’s now ready for use. So that’s Sterigenics.